Skip to main content
Theralase Technologies Inc. logo

Theralase Technologies Inc. — Investor Relations & Filings

Ticker · TLT ISIN · CA88337V1004 LEI · 529900NI3Y8GLE2IBF28 TSXV Manufacturing
Open in API
Filings indexed 229 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country CA Canada
Listing TSXV TLT

About Theralase Technologies Inc.

https://theralase.com/

Theralase Technologies Inc. designs, develops, manufactures, and markets patented laser technology platforms for both bio-stimulative and bio-destructive medical applications. The company operates two core divisions. The first is Cool Laser Therapy (CLT), which utilizes proprietary super-pulsed laser systems for therapeutic purposes, focusing on pain management, inflammation reduction, tissue repair, and the effective elimination of chronic knee pain. The second is Anti-Cancer Therapy (ACT), which employs patented light-activated Photo Dynamic Compounds (PDCs) combined with laser technology for destructive applications, specifically targeting the safe and effective destruction of cancer, bacteria, and viruses.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 1% confidence The document is a formal transmission from TSX Trust Company confirming the issuance of the Notice of Record and Meeting Dates for an upcoming Annual General and Special Meeting. It is addressed to exchanges and commissions rather than shareholders, and it does not itself constitute a proxy solicitation document nor an AGM presentation. It simply informs regulators of meeting logistics. This falls under general regulatory announcements that do not fit other specific categories, making it a Regulatory Filing (RNS).
2026-04-23 English
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a TSX Trust Company notice confirming the dispatch of the notice of record and meeting dates for the upcoming Annual General and Special Meeting of security holders. It details proxy‐related material distribution (record dates, meeting date, voting classes), which fits the definition for Proxy Solicitation & Information Statement (PSI) – materials sent to shareholders to provide information and request votes for meetings. It is not the full meeting materials themselves but the official notice relating to proxy solicitation.
2026-04-23 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2026-04-20 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2026-04-20 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory form (Form 45-106F1) reporting an exempt distribution under National Instrument 45-106. It provides detailed distribution, purchaser, compensation, and issuer information required by securities regulators. This is neither an earnings release nor an annual/interim report but a formal regulatory filing. No more specific category applies, so it falls under the general Regulatory Filings category (RNS).
2026-04-20 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a news release describing preclinical study results and forward-looking statements, rather than a financial report, management discussion, earnings release, or regulatory filing like an annual or interim report. It does not announce voting results, dividends, financing, or corporate governance changes. It is not a presentation deck or transcript. It is a corporate press release with scientific data aimed at investors and the public, which falls into the fallback category for miscellaneous regulatory announcements and press releases. Therefore, it should be classified as a Regulatory Filings (RNS) document.
2026-04-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.